IBEX Technologies Inc (IBT.V)

IBT.V on TSX Venture Exchange

0.06CAD
30 Jul 2015
Change (% chg)

-- (--)
Prev Close
$0.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,360
52-wk High
$0.10
52-wk Low
$0.05

IBT.V

Chart for IBT.V

About

IBEX Technologies Inc is a Canada-based Company that manufactures and markets enzymes for biomedical use. The company produces a family of high purity recombinant glycosaminoglycan (GAG) lyases, namely Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC and Chondroitinase B. It also produces a series of arthritis... (more)
No analyst recommendations are available for IBT.V.

Overall

Beta: 1.09
Market Cap(Mil.): $1.48
Shares Outstanding(Mil.): 24.70
Dividend: --
Yield (%): --

Financials

  IBT.V Industry Sector
P/E (TTM): -- 408.24 40.68
EPS (TTM): -0.04 -- --
ROI: -18.62 -5.70 15.78
ROE: -23.69 -5.72 16.82
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Wright Reports
$75.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks